Boston Scientific Gross Margin 2010-2023 | BSX
Boston Scientific Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2023-12-31 | $14.24B | $9.90B | 69.49% |
2023-09-30 | $13.76B | $9.55B | 69.40% |
2023-06-30 | $13.40B | $9.31B | 69.49% |
2023-03-31 | $13.05B | $9.00B | 69.02% |
2022-12-31 | $12.68B | $8.73B | 68.81% |
2022-09-30 | $12.57B | $8.65B | 68.83% |
2022-06-30 | $12.33B | $8.49B | 68.87% |
2022-03-31 | $12.16B | $8.39B | 68.99% |
2021-12-31 | $11.89B | $8.18B | 68.78% |
2021-09-30 | $11.47B | $7.73B | 67.41% |
2021-06-30 | $11.20B | $7.49B | 66.89% |
2021-03-31 | $10.12B | $6.57B | 64.90% |
2020-12-31 | $9.91B | $6.45B | 65.05% |
2020-09-30 | $10.11B | $6.79B | 67.19% |
2020-06-30 | $10.16B | $6.93B | 68.25% |
2020-03-31 | $10.79B | $7.59B | 70.40% |
2019-12-31 | $10.74B | $7.62B | 70.97% |
2019-09-30 | $10.39B | $7.40B | 71.18% |
2019-06-30 | $10.08B | $7.19B | 71.32% |
2019-03-31 | $9.94B | $7.07B | 71.11% |
2018-12-31 | $9.82B | $7.01B | 71.36% |
2018-09-30 | $9.67B | $6.91B | 71.49% |
2018-06-30 | $9.50B | $6.78B | 71.35% |
2018-03-31 | $9.27B | $6.65B | 71.78% |
2017-12-31 | $9.05B | $6.46B | 71.34% |
2017-09-30 | $8.83B | $6.29B | 71.27% |
2017-06-30 | $8.71B | $6.22B | 71.38% |
2017-03-31 | $8.58B | $6.08B | 70.86% |
2016-12-31 | $8.39B | $5.96B | 71.09% |
2016-09-30 | $8.17B | $5.79B | 70.88% |
2016-06-30 | $7.96B | $5.63B | 70.78% |
2016-03-31 | $7.67B | $5.45B | 70.99% |
2015-12-31 | $7.48B | $5.30B | 70.94% |
2015-09-30 | $7.39B | $5.23B | 70.77% |
2015-06-30 | $7.34B | $5.17B | 70.45% |
2015-03-31 | $7.37B | $5.18B | 70.26% |
2014-12-31 | $7.38B | $5.17B | 70.05% |
2014-09-30 | $7.33B | $5.13B | 69.91% |
2014-06-30 | $7.22B | $5.05B | 70.00% |
2014-03-31 | $7.16B | $5.02B | 70.19% |
2013-12-31 | $7.14B | $4.97B | 69.56% |
2013-09-30 | $7.13B | $4.93B | 69.12% |
2013-06-30 | $7.13B | $4.88B | 68.45% |
2013-03-31 | $7.14B | $4.85B | 67.86% |
2012-12-31 | $7.25B | $4.90B | 67.60% |
2012-09-30 | $7.28B | $4.85B | 66.65% |
2012-06-30 | $7.42B | $4.87B | 65.63% |
2012-03-31 | $7.56B | $4.90B | 64.84% |
2011-12-31 | $7.62B | $4.96B | 65.11% |
2011-09-30 | $7.78B | $5.12B | 65.82% |
2011-06-30 | $7.82B | $5.22B | 66.73% |
2011-03-31 | $7.77B | $5.20B | 66.97% |
2010-12-31 | $7.81B | $5.21B | 66.71% |
2010-09-30 | $7.88B | $5.23B | 66.38% |
2010-06-30 | $7.99B | $5.34B | 66.77% |
2010-03-31 | $8.14B | $5.51B | 67.66% |
2009-12-31 | $8.19B | $5.61B | 68.54% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $99.865B | $14.240B |
Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $193.473B | 25.11 |
Stryker (SYK) | United States | $133.123B | 33.06 |
Medtronic (MDT) | Ireland | $111.139B | 15.73 |
EssilorLuxottica (ESLOY) | France | $102.775B | 0.00 |
Lonza Group Ag (LZAGY) | Switzerland | $43.832B | 0.00 |
Haleon (HLN) | United Kingdom | $38.831B | 30.04 |
ResMed (RMD) | United States | $28.562B | 28.56 |
Terumo (TRUMY) | Japan | $27.589B | 38.84 |
Zimmer Biomet Holdings (ZBH) | United States | $26.224B | 16.91 |
Baxter (BAX) | United States | $21.095B | 15.39 |
Koninklijke Philips (PHG) | Netherlands | $18.610B | 14.84 |
Insulet (PODD) | United States | $11.574B | 60.85 |
Smith & Nephew SNATS (SNN) | United Kingdom | $11.401B | 0.00 |
Demant (WILYY) | Denmark | $11.148B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $9.711B | 28.93 |
BellRing Brands (BRBR) | United States | $7.779B | 41.82 |
Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
GN Store Nord (GNNDY) | Denmark | $4.150B | 26.87 |
Haemonetics (HAE) | United States | $4.146B | 21.20 |
Lantheus Holdings (LNTH) | United States | $4.027B | 10.40 |
Prestige Consumer Healthcare (PBH) | United States | $3.575B | 16.90 |
Envista Holdings (NVST) | United States | $3.561B | 13.57 |
Neogen (NEOG) | United States | $3.248B | 31.25 |
QuidelOrtho (QDEL) | United States | $3.142B | 11.41 |
Green Thumb Industries (GTBIF) | United States | $2.981B | 94.47 |
ICU Medical (ICUI) | United States | $2.433B | 18.32 |
TG Therapeutics (TGTX) | United States | $2.384B | 772.00 |
Maravai LifeSciences Holdings (MRVI) | United States | $2.097B | 0.00 |
Owens & Minor (OMI) | United States | $2.036B | 19.54 |
Verano Holdings (VRNOF) | United States | $1.879B | 0.00 |
InMode (INMD) | Israel | $1.736B | 8.99 |
National Vision Holdings (EYE) | United States | $1.710B | 53.24 |
Agios Pharmaceuticals (AGIO) | United States | $1.633B | 0.00 |
AdaptHealth (AHCO) | United States | $1.499B | 11.28 |
LeMaitre Vascular (LMAT) | United States | $1.470B | 48.81 |
AtriCure (ATRC) | United States | $1.407B | 0.00 |
Warby Parker (WRBY) | United States | $1.254B | 0.00 |
MacroGenics (MGNX) | United States | $0.888B | 0.00 |
Quanterix (QTRX) | United States | $0.834B | 0.00 |
BioLife Solutions (BLFS) | United States | $0.820B | 0.00 |
Evolus (EOLS) | United States | $0.803B | 0.00 |
Cresco Labs (CRLBF) | United States | $0.706B | 0.00 |
VAREX IMAGING (VREX) | United States | $0.702B | 15.18 |
Canopy Growth (CGC) | Canada | $0.659B | 0.00 |
Valneva SE (VALN) | France | $0.543B | 0.00 |
Jin Medical (ZJYL) | China | $0.527B | 0.00 |
PetIQ (PETQ) | United States | $0.524B | 19.55 |
TerrAscend (TSNDF) | Canada | $0.521B | 0.00 |
Phibro Animal Health (PAHC) | United States | $0.520B | 11.26 |
OraSure Technologies (OSUR) | United States | $0.465B | 7.70 |
Biote (BTMD) | United States | $0.440B | 4.18 |
ZimVie (ZIMV) | United States | $0.431B | 26.53 |
Surmodics (SRDX) | United States | $0.402B | 43.40 |
Zynex (ZYXI) | United States | $0.397B | 45.74 |
Viemed Healthcare (VMD) | United States | $0.352B | 34.96 |
Sanara MedTech (SMTI) | United States | $0.317B | 0.00 |
Cerus (CERS) | United States | $0.315B | 0.00 |
Organigram Holdings (OGI) | Canada | $0.253B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.247B | 14.91 |
TriSalus Life Sciences (TLSI) | United States | $0.245B | 0.00 |
Aurora Cannabis (ACB) | Canada | $0.230B | 0.00 |
Omeros (OMER) | United States | $0.218B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.199B | 0.00 |
Quipt Home Medical (QIPT) | United States | $0.182B | 0.00 |
Ayr Wellness (AYRWF) | United States | $0.173B | 0.00 |
High Tide (HITI) | Canada | $0.155B | 0.00 |
Jushi Holdings (JUSHF) | United States | $0.143B | 0.00 |
Fonar (FONR) | United States | $0.137B | 11.80 |
InterCure (INCR) | Israel | $0.116B | 19.61 |
Societal CDMO (SCTL) | United States | $0.115B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.110B | 0.00 |
FitLife Brands (FTLF) | United States | $0.107B | 20.86 |
Safety Shot (SHOT) | United States | $0.100B | 0.00 |
MariMed (MRMD) | United States | $0.098B | 0.00 |
Brainsway (BWAY) | Israel | $0.091B | 0.00 |
Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
Chimerix (CMRX) | United States | $0.088B | 0.00 |
Veru (VERU) | United States | $0.084B | 0.00 |
Eagleford Energy (GRUSF) | United States | $0.083B | 45.50 |
Zevia PBC (ZVIA) | United States | $0.070B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.065B | 4.27 |
Rockwell Medical (RMTI) | United States | $0.048B | 0.00 |
Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.047B | 0.00 |
Bright Green (BGXX) | United States | $0.045B | 0.00 |
Apyx Medical (APYX) | United States | $0.044B | 0.00 |
Modular Medical (MODD) | United States | $0.042B | 0.00 |
ImmuCell (ICCC) | United States | $0.040B | 0.00 |
United-Guardian (UG) | United States | $0.035B | 13.52 |
FSD PHARMA (HUGE) | Canada | $0.028B | 0.00 |
Agape ATP (ATPC) | $0.027B | 0.00 | |
Exagen (XGN) | United States | $0.027B | 0.00 |
Nephros (NEPH) | United States | $0.023B | 0.00 |
Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
Flora Growth (FLGC) | United States | $0.017B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
GUARDION HEALTH (GHSI) | United States | $0.012B | 0.00 |
ProSomnus (OSA) | United States | $0.010B | 0.00 |
NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
Leafly Holdings (LFLY) | United States | $0.007B | 0.00 |
GlucoTrack (GCTK) | United States | $0.007B | 0.00 |
IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
Sharps Technology (STSS) | United States | $0.005B | 0.00 |
Innovative Eyewear (LUCY) | United States | $0.004B | 0.00 |
Senestech (SNES) | United States | $0.004B | 0.00 |
Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
Smart For Life (SMFL) | United States | $0.001B | 0.00 |
Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
SNDL (SNDL) | Canada | $0.000B | 0.00 |